Nuclear Morphometry in Ovarian Cancer Prognosis
Author Information
Author(s): Liu C Q, Sasaki H, Fahey M T, Sakamoto A, Sato S, Tanaka T
Primary Institution: The Jikei University School of Medicine
Hypothesis
Can nuclear morphometry predict outcomes in patients with TNM stage T1 ovarian clear cell adenocarcinoma?
Conclusion
Nuclear morphometric characteristics, particularly the presence of giant nuclear cells and nuclear irregularity, can help predict outcomes in early stage ovarian clear cell adenocarcinoma patients.
Supporting Evidence
- The presence of giant nuclear cells was positively associated with death.
- Nuclear irregularity was positively associated with both death and disease recurrence.
- A combination of giant nuclear cell presence or nuclear irregularity was a useful prognostic indicator.
Takeaway
This study looked at how the shape and size of cell nuclei can help doctors predict how well patients with a specific type of ovarian cancer might do.
Methodology
Nuclear morphometry was used to study the relations among morphometric variables, clinical prognostic factors, and outcomes in patients.
Participant Demographics
Patients with TNM stage T1 ovarian clear cell adenocarcinoma.
Statistical Information
P-Value
0.02
Statistical Significance
p=0.02
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website